Assessment of the efficacy and toxicity of (131)I-metaiodobenzylguanidine therapy for metastatic neuroendocrine tumours February 23, 2012 by amaranwosu Leave a comment This is a review of 131I-MIBG therapy for metastatic neuroendocrine tumours published in the British Journal of Cancer. http://www.nature.com/bjc/journal/v98/n6/full/6604273a.html Share this: Share on X (Opens in new window) X Share on Facebook (Opens in new window) Facebook Share on LinkedIn (Opens in new window) LinkedIn Like Loading...